| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 96.69B | 90.11B | 79.90B | 71.25B | 62.32B | 57.21B |
| Gross Profit | 20.37B | 18.90B | 16.57B | 15.53B | 15.66B | 12.93B |
| EBITDA | 9.19B | 7.85B | 5.49B | 5.22B | 6.16B | 3.98B |
| Net Income | 4.98B | 3.83B | 2.90B | 2.78B | 4.42B | 2.60B |
Balance Sheet | ||||||
| Total Assets | 149.50B | 151.16B | 152.10B | 124.15B | 116.54B | 95.71B |
| Cash, Cash Equivalents and Short-Term Investments | 36.20B | 20.92B | 22.47B | 34.90B | 34.15B | 27.70B |
| Total Debt | 82.42B | 86.52B | 86.81B | 59.02B | 57.86B | 48.65B |
| Total Liabilities | 112.82B | 114.26B | 118.12B | 92.18B | 86.54B | 69.14B |
| Stockholders Equity | 36.69B | 36.89B | 33.98B | 31.97B | 30.00B | 26.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -15.00M | -33.93B | -2.44B | 215.00M | -7.01B |
| Operating Cash Flow | 0.00 | 625.00M | -33.37B | -1.83B | 419.00M | -6.89B |
| Investing Cash Flow | 0.00 | -574.00M | -5.84B | 2.44B | -2.41B | -45.00M |
| Financing Cash Flow | 0.00 | -1.60B | 26.79B | 140.00M | 8.35B | 12.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ¥101.27B | 21.37 | ― | 2.19% | 3.42% | 7.82% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥108.56B | 6.95 | ― | 2.93% | 14.99% | 73.33% | |
61 Neutral | ¥114.58B | 7.31 | 15.81% | 2.93% | 12.51% | 12.42% | |
57 Neutral | ¥61.84B | 9.29 | ― | 2.89% | 4.32% | 11.25% | |
52 Neutral | ¥39.73B | 21.02 | ― | 0.45% | 23.11% | 8.31% | |
49 Neutral | ¥17.71B | 4.91 | ― | 3.54% | 12.77% | 32.07% |